TY  - JOUR
AU  - Bardaji, Alfredo
AU  - Leal, Manuel
AU  - Arrarte, Vicente
AU  - Garcia-Moll, Xavier
AU  - Pérez de Isla, Leopoldo
AU  - Bueno, Hector
PY  - 2017
DO  - 10.1111/1755-5922.12237
UR  - http://hdl.handle.net/20.500.12105/11262
AB  - Real-world, country-specific studies of dual antiplatelet therapy (DAPT) duration among survivors of acute coronary syndrome (ACS) are important for improving long-term prognosis.To investigate DAPT duration after hospital discharge for ACS in...
LA  - eng
PB  - Wiley
KW  - Percutaneous Coronary Intervention
KW  - Acute Coronary Syndrome
KW  - Administration, Oral
KW  - Aged
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Fibrinolytic Agents
KW  - Follow-Up Studies
KW  - Hemorrhage
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Patient Discharge
KW  - Platelet Aggregation Inhibitors
KW  - Practice Patterns, Physicians'
KW  - Prospective Studies
KW  - Registries
KW  - Risk Factors
KW  - Spain
KW  - Time Factors
KW  - Treatment Outcome
TI  - Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.
TY  - journal article
ER  -